API peptides and protein-based drugs are promising therapeutics for the treatment of a variety of metabolic and oncological disorders. More than 100 approved peptide-based therapeutics are currently available in the market, while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development.
Recommended Buyer's Guides
Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles. The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract manufacturing services.
Discover the top peptide API manufacturers in contract manufacturing
Pharmaceutical Technology has listed the leading contract manufacturers of API biologics (protein and peptide) based on its intel, insights, and decades-long experience in the pharmaceutical sector. The list includes companies that provide various products and services including, but not limited to:
- Manufacturing of reagents for peptide synthesis
- Large-scale manufacturing of peptides
- Manufacturing of biologically active peptides and complex organic molecules
- Production of therapeutic proteins, such as soluble proteins and lipoproteins
- Process qualification
- Stability testing
- Product purification
- Downstream processing
- GMP synthesis
- Synthesis and production of custom peptides, and
- Tech transfer support for a wide range of GMP API clinical peptide projects
The information contained within the download document is intended for API peptide and API protein manufacturers, pharmaceutical executives, peptide synthesis chemists, purification associates, and any other individual involved in the manufacturing of API proteins and peptides.
The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your hiring decision.
See Also:
Contract manufacturing opportunities in API peptides and proteins
Advancements in drug design have led to the development of new drug molecules in the form of API peptides and proteins. Selective delivery of these molecules at well-defined dosing regimens and preserving their structural integrity has, however, remained challenging. New techniques are being applied to meet the challenges associated with the formulation and delivery of API peptides and proteins.
Contract peptide API manufacturers can benefit by investing in new technologies and capabilities to handle the production of complex peptide and protein molecules. Contract manufacturers are also exploring technologies that support the large-scale manufacturing of proteins and peptides such as lyophilisation, spray drying and microbial expression.